![Effects of apomorphine at dose 5 and 10 mg/kg on stereotypies in trace... | Download Scientific Diagram Effects of apomorphine at dose 5 and 10 mg/kg on stereotypies in trace... | Download Scientific Diagram](https://www.researchgate.net/publication/263097544/figure/fig3/AS:392372136497156@1470560215328/Effects-of-apomorphine-at-dose-5-and-10-mg-kg-on-stereotypies-in-trace-amine-associated.png)
Effects of apomorphine at dose 5 and 10 mg/kg on stereotypies in trace... | Download Scientific Diagram
![Apomorphine subcutaneous infusion reduces dopaminergic dosage whilst maintaining motor benefits in Parkinson's disease: A prospective analysis of Thai Apomorphine Registry - MDS Abstracts Apomorphine subcutaneous infusion reduces dopaminergic dosage whilst maintaining motor benefits in Parkinson's disease: A prospective analysis of Thai Apomorphine Registry - MDS Abstracts](https://www.mdsabstracts.org/wp-content/uploads/2020/09/0417_0603_001621_003.png)
Apomorphine subcutaneous infusion reduces dopaminergic dosage whilst maintaining motor benefits in Parkinson's disease: A prospective analysis of Thai Apomorphine Registry - MDS Abstracts
![Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial - The Lancet Neurology Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial - The Lancet Neurology](https://www.thelancet.com/cms/attachment/5a5b4ae1-081c-4838-87c8-d173ef2e247b/gr1_lrg.jpg)
Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial - The Lancet Neurology
![A case series of rapid titration of subcutaneous apomorphine in Parkinson's disease | British Journal of Neuroscience Nursing A case series of rapid titration of subcutaneous apomorphine in Parkinson's disease | British Journal of Neuroscience Nursing](https://www.magonlinelibrary.com/cms/10.12968/bjnn.2016.12.2.70/asset/images/medium/bjnn.2016.12.2.70_t03.jpg)
A case series of rapid titration of subcutaneous apomorphine in Parkinson's disease | British Journal of Neuroscience Nursing
![Pharmacokinetics and Comparative Bioavailability of Apomorphine Sublingual Film and Subcutaneous Apomorphine Formulations in Patients with Parkinson's Disease and “OFF” Episodes: Results of a Randomized, Three-Way Crossover, Open-Label Study | SpringerLink Pharmacokinetics and Comparative Bioavailability of Apomorphine Sublingual Film and Subcutaneous Apomorphine Formulations in Patients with Parkinson's Disease and “OFF” Episodes: Results of a Randomized, Three-Way Crossover, Open-Label Study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40120-021-00251-6/MediaObjects/40120_2021_251_Fig2_HTML.png)
Pharmacokinetics and Comparative Bioavailability of Apomorphine Sublingual Film and Subcutaneous Apomorphine Formulations in Patients with Parkinson's Disease and “OFF” Episodes: Results of a Randomized, Three-Way Crossover, Open-Label Study | SpringerLink
![A Randomized Thorough QT Study of Apomorphine Sublingual Film in Patients With Parkinson's Disease - Stocchi - 2022 - Clinical Pharmacology in Drug Development - Wiley Online Library A Randomized Thorough QT Study of Apomorphine Sublingual Film in Patients With Parkinson's Disease - Stocchi - 2022 - Clinical Pharmacology in Drug Development - Wiley Online Library](https://accp1.onlinelibrary.wiley.com/cms/asset/67a21776-3a5f-4884-876f-3856cc42382b/cpdd1147-fig-0001-m.jpg)
A Randomized Thorough QT Study of Apomorphine Sublingual Film in Patients With Parkinson's Disease - Stocchi - 2022 - Clinical Pharmacology in Drug Development - Wiley Online Library
![Dose-response curves of the disruption of PPI induced by apomorphine... | Download Scientific Diagram Dose-response curves of the disruption of PPI induced by apomorphine... | Download Scientific Diagram](https://www.researchgate.net/publication/40897627/figure/fig1/AS:601693045669899@1520466209322/Dose-response-curves-of-the-disruption-of-PPI-induced-by-apomorphine-panel-a-or-by.png)
Dose-response curves of the disruption of PPI induced by apomorphine... | Download Scientific Diagram
![Apomorphine subcutaneous infusion reduces dopaminergic dosage whilst maintaining motor benefits in Parkinson's disease: A prospective analysis of Thai Apomorphine Registry - MDS Abstracts Apomorphine subcutaneous infusion reduces dopaminergic dosage whilst maintaining motor benefits in Parkinson's disease: A prospective analysis of Thai Apomorphine Registry - MDS Abstracts](https://www.mdsabstracts.org/wp-content/uploads/2020/09/0417_0603_001621_004.png)
Apomorphine subcutaneous infusion reduces dopaminergic dosage whilst maintaining motor benefits in Parkinson's disease: A prospective analysis of Thai Apomorphine Registry - MDS Abstracts
![Structure–Functional–Selectivity Relationship Studies of Novel Apomorphine Analogs to Develop D1R/D2R Biased Ligands | ACS Medicinal Chemistry Letters Structure–Functional–Selectivity Relationship Studies of Novel Apomorphine Analogs to Develop D1R/D2R Biased Ligands | ACS Medicinal Chemistry Letters](https://pubs.acs.org/cms/10.1021/acsmedchemlett.9b00575/asset/images/medium/ml9b00575_0003.gif)
Structure–Functional–Selectivity Relationship Studies of Novel Apomorphine Analogs to Develop D1R/D2R Biased Ligands | ACS Medicinal Chemistry Letters
![Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study - ScienceDirect Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S135380202100016X-gr1.jpg)
Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study - ScienceDirect
![Safety of sublingual apomorphine film (APL-130277) for the treatment of OFF episodes in patients with Parkinson's disease: Preliminary Results from a Phase III Study - MDS Abstracts Safety of sublingual apomorphine film (APL-130277) for the treatment of OFF episodes in patients with Parkinson's disease: Preliminary Results from a Phase III Study - MDS Abstracts](https://www.mdsabstracts.org/wp-content/uploads/2017/05/0037-001034_001.jpg)
Safety of sublingual apomorphine film (APL-130277) for the treatment of OFF episodes in patients with Parkinson's disease: Preliminary Results from a Phase III Study - MDS Abstracts
![FDA Approves Apomorphine Sublingual Film for Treatment of OFF Periods in Parkinson Disease - Practical Neurology FDA Approves Apomorphine Sublingual Film for Treatment of OFF Periods in Parkinson Disease - Practical Neurology](https://core4.bmctoday.net/storage/images/MovementDisordersTable1_1590101721.jpg)
FDA Approves Apomorphine Sublingual Film for Treatment of OFF Periods in Parkinson Disease - Practical Neurology
![Challenges and trends in apomorphine drug delivery systems for the treatment of Parkinson's disease - ScienceDirect Challenges and trends in apomorphine drug delivery systems for the treatment of Parkinson's disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1818087617306189-gr1.jpg)